CSPC Pharma quarterly net higher

Business | 18 Nov 2019 3:50 pm

China pharmaceutical products provider CSPC Pharmaceutical (1093) said net profit for the first three quarters increased by 24 percent year-on-year to 2.81 billion yuan (HK$3.14 billion).

Revenue grew by 27.5 percent to 16.76 billion yuan from a year before.

The basic earnings per share were 45.15 fen.

 

Search Archive

Advanced Search
December 2019
S M T W T F S

Today's Standard



Yearly Magazine

Yearly Magazine